Marathon Oil (NYSE:MRO) had its target price upped by equities researchers at Morgan Stanley from $15.00 to $21.00 in a research report issued on Wednesday. The firm currently has an “equal weight” rating on the oil and gas producer’s stock. Morgan Stanley’s target price suggests a potential upside of 11.46% from the stock’s current price.
A number of other brokerages have also recently weighed in on MRO. Zacks Investment Research upgraded shares of Marathon Oil from a “hold” rating to a “buy” rating and set a $21.00 target price for the company in a report on Monday, January 15th. Jefferies Group restated a “hold” rating and set a $19.80 target price on shares of Marathon Oil in a report on Friday, January 19th. BMO Capital Markets restated a “hold” rating and set a $21.00 target price on shares of Marathon Oil in a report on Thursday, January 11th. JPMorgan Chase & Co. set a $20.00 target price on shares of Marathon Oil and gave the stock a “hold” rating in a report on Wednesday, January 17th. Finally, Bank of America upgraded shares of Marathon Oil from a “neutral” rating to a “buy” rating and set a $21.00 target price for the company in a report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $17.52.
Shares of Marathon Oil (MRO) traded up $0.16 during trading hours on Wednesday, reaching $18.84. 8,837,978 shares of the company were exchanged, compared to its average volume of 11,460,000. The company has a market capitalization of $16,010.00, a PE ratio of -7.36, a price-to-earnings-growth ratio of 7.64 and a beta of 2.38. Marathon Oil has a 1 year low of $10.55 and a 1 year high of $19.52. The company has a quick ratio of 2.02, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.
A number of institutional investors have recently bought and sold shares of MRO. Cerebellum GP LLC acquired a new stake in shares of Marathon Oil during the 4th quarter valued at $117,000. FTB Advisors Inc. boosted its stake in shares of Marathon Oil by 49.8% during the 4th quarter. FTB Advisors Inc. now owns 8,080 shares of the oil and gas producer’s stock valued at $144,000 after buying an additional 2,687 shares during the period. Mackenzie Financial Corp acquired a new stake in shares of Marathon Oil during the 3rd quarter valued at $149,000. Valeo Financial Advisors LLC acquired a new stake in shares of Marathon Oil during the 3rd quarter valued at $159,000. Finally, Intact Investment Management Inc. acquired a new stake in shares of Marathon Oil during the 3rd quarter valued at $173,000. 80.28% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Marathon Oil (MRO) Price Target Raised to $21.00 at Morgan Stanley” was published by American Banking and Market News and is the sole property of of American Banking and Market News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/28/marathon-oil-mro-price-target-raised-to-21-00-at-morgan-stanley.html.
Marathon Oil Company Profile
Marathon Oil Corporation is an exploration and production (E&P) company. The Company operates through three segments: North America E&P, International E&P and Oil Sands Mining. The North America E&P segment explores for, produces and markets crude oil and condensate, natural gas liquids (NGLs) and natural gas in North America.
